News

Nokia's Successful Share Buyback Program: Key Highlights

Nokia's Successful Share Buyback Program: Key Highlights

Nokia Completes Its Share Buyback Initiative Successfully

Nokia Corporation has reached a significant milestone by successfully concluding its recent share buyback program. This initiative began on March 18, 2024, and saw its scope expanded by July 19, 2024. A substantial total of 157,646,220 shares were repurchased, with the average acquisition price resting at approximately €3.81.

Impact of the Buyback on Nokia's Equity Structure

With the successful completion of this initiative, Nokia’s unrestricted equity has decreased by €600 million. This move reflects the company's strategy to enhance shareholder value; the firm currently holds a total of 209,702,510 treasury shares. The shares were acquired through directed repurchases conducted via public trading on the regulated market of Nasdaq Helsinki along with selected multilateral trading facilities.

Nokia's Future Plans for the Repurchased Shares

Nokia plans to cancel the acquired shares in December 2024. This step is customary following a share buyback, reflecting a strategy to potentially increase the value of remaining shares by reducing the overall number in circulation.

Nokia's Vision and Technological Innovations

Nokia is renowned for being a frontrunner in B2B technology innovation, concentrating on developing networks that are intelligent and interactive. The company is dedicated to producing technologies that foster global collaboration, with expertise across mobile, fixed, and cloud networks.

Emphasizing Open Network Architecture

Nokia's network architecture is notably open, ensuring seamless integration across various ecosystems. The firm's high-performance networks are strategically developed to unlock new monetization opportunities and scalability for service providers, enterprises, and partners worldwide. Stakeholders place their trust in Nokia to provide secure, reliable, and sustainable network solutions that not only address current demands but also collaborate on the future's digital services and applications.

Commitment to Long-term Innovation

Through its unwavering focus on technology and innovation, especially via its esteemed Nokia Bell Labs, the company is recognized for its ability to create substantial value through intellectual property and long-term research commitments. Nokia continues to be a leader in developing efficient and forward-thinking network solutions.

Frequently Asked Questions

What is the purpose of Nokia's share buyback program?

The share buyback program aims to enhance shareholder value by reducing the total number of shares in circulation, potentially increasing the value of the existing shares.

How many shares did Nokia repurchase?

Nokia successfully repurchased a total of 157,646,220 shares during the buyback program.

How does the share buyback impact the company's equity?

The completion of the buyback resulted in a reduction of Nokia's unrestricted equity by €600 million.

What will happen to the repurchased shares?

Nokia plans to cancel the repurchased shares in December 2024 as part of the buyback process.

What innovations is Nokia known for?

Nokia is recognized for its contributions to mobile, fixed, and cloud networks, with a strong emphasis on creating technologies for global collaboration and seamless integration.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cepheid's FDA Clearance Boosts Hemorrhagic Fever Test

Updated Category News Views 81

Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...

Continue Reading
Icahn Faces $225M Q3 Loss, But CVR Deal Shines

Updated Category News Views 30

Icahn Enterprises Stumbles in Q3, Losses Widen When a company's financial report starts with a loss, it's like stepping into a bar fight expecting cheers—you’re bound to get more than you bargained for. Icahn Enterprises L.P.'s third quarter report isn't exactly a rosy picture. We're staring down the barrel of a net loss of $225 million, a sharp contrast to the $287...

Continue Reading
MINISO Prepares to Reveal September 2026 Results

Updated Category News Views 74

News flash, folks — MINISO Group, that quirky IP-driven retailer we all have an eye on, has set the stage for its next big reveal. Come November 17, 2026, they’re gonna lay down their financial cards for the September quarter. It’s prime time for any investor keen on dissecting their performance and plans for the future. What the Call Means for Stakeholders MINISO's...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 57

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 37

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
RepData's New Platform Redefines Market Research Game

Updated Category News Views 34

Ever look at your market research and think, 'Is this really the best we can do?' RepData just rolled up like they own the place with their Verified Intelligence Platform (VIP), promising to make those wild data quality doubts a thing of the past. RepData’s Game-Changer in Research RepData's stepping into the ring with their VIP, aiming to shake up the way research...

Continue Reading
Oracle's $20 Billion Offering: What Investors Need to Know

Updated Category News Views 118

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 98

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
Handle Plumbing Emergencies Swiftly, Expert Advises

Updated Category News Views 49

Fast Response Crucial in Plumbing Crises It's like nature's way of testing your mettle: a sudden plumbing emergency can make any homeowner feel like they're in over their head. The trick lies in how fast you act, and let me tell you, speed is everything in these situations. If you’ve never stared down a burst pipe or felt your heart drop at an overflowing toilet,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth and Trends in Nuclear Medicine

Updated Category News Views 326

Nuclear Medicine Market Trends and Growth Projections Nuclear medicine is becoming an essential part of modern healthcare systems, offering significant diagnostic and therapeutic benefits. Recent industry analysis shows that the nuclear medicine market, valued at US$ 5.2 billion in 2022, is projected to grow to an astounding US$ 11.4 billion by 2031. This growth...

Continue Reading
Bitcoin Resilience: Experts Forecast Continued Growth Amid Dip

Updated Category News Views 107

Experts Forecast Bitcoin's Continued Growth In recent discussions, cryptocurrency experts have expressed a common belief that Bitcoin's long-term trajectory remains robust despite current fluctuations. Bitcoin has faced challenges in the short term, but the overarching consensus suggests that its bull market is far from over. The Impact of Federal Reserve Policies...

Continue Reading
Iovance Investors Urged to Act Before the July 14 Deadline

Updated Category News Views 170

Important Notice for Iovance Investors Levi & Korsinsky, LLP is reaching out to investors of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) regarding a class action securities lawsuit. This notice serves to inform shareholders of the impending deadline for becoming a lead plaintiff, which is set for July 14, 2025. Class Action Overview The legal action aims to recover...

Continue Reading
Startek® South Africa Achieves Best Employer Brand Award

Updated Category News Views 256

Startek® South Africa Celebrates Employer Branding Success Startek®, a leader in global customer experience solutions, is making waves in the industry with its recent accolade at the South Africa Leadership Awards. Startek's South Africa operations received the prestigious Best Employer Brand Award for 2025, recognizing their exceptional approach to employee engagement...

Continue Reading
ESS Tech Launches Energy Center™ Product for Sustainable Energy

Updated Category News Views 220

ESS Tech Introduces Energy Center™ Product ESS Tech, Inc. (NYSE: GWH), a frontrunner in the field of long-duration energy storage systems, has proudly announced the commercial launch of its innovative Energy Center™ product. This milestone comes with the successful delivery of multiple systems to a prominent utility in Florida, along with the completion of...

Continue Reading